These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7573515)

  • 1. Cardiac muscle diseases in genetically engineered mice: evolution of molecular physiology.
    Chien KR
    Am J Physiol; 1995 Sep; 269(3 Pt 2):H755-66. PubMed ID: 7573515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological assessment of complex cardiac phenotypes in genetically engineered mice.
    Christensen G; Wang Y; Chien KR
    Am J Physiol; 1997 Jun; 272(6 Pt 2):H2513-24. PubMed ID: 9227526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of molecular biology in understanding the formation of congenital cardiomyopathies in humans].
    Bonnet D
    J Soc Biol; 2003; 197(2):195-9. PubMed ID: 12910635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for studying cardiovascular phenotypes in genetically manipulated mice.
    Becker KD; Gottshall KR; Chien KR
    Hypertension; 1996 Mar; 27(3 Pt 2):495-501. PubMed ID: 8613192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological phenotyping in genetically engineered mice.
    Berul CI
    Physiol Genomics; 2003 May; 13(3):207-16. PubMed ID: 12746465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac neural crest.
    Stoller JZ; Epstein JA
    Semin Cell Dev Biol; 2005 Dec; 16(6):704-15. PubMed ID: 16054405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular aspects of congenital heart diseases].
    Bajolle F; Zaffran S; Bonnet D
    Arch Mal Coeur Vaiss; 2007 May; 100(5):484-9. PubMed ID: 17646780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New frontiers in molecular pediatric cardiology.
    Dees E; Baldwin HS
    Curr Opin Pediatr; 2002 Oct; 14(5):627-33. PubMed ID: 12352259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development.
    Davis RP; van den Berg CW; Casini S; Braam SR; Mummery CL
    Trends Mol Med; 2011 Sep; 17(9):475-84. PubMed ID: 21703926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel conditional mouse model for Nkx2-5 reveals transcriptional regulation of cardiac ion channels.
    Furtado MB; Wilmanns JC; Chandran A; Tonta M; Biben C; Eichenlaub M; Coleman HA; Berger S; Bouveret R; Singh R; Harvey RP; Ramialison M; Pearson JT; Parkington HC; Rosenthal NA; Costa MW
    Differentiation; 2016; 91(1-3):29-41. PubMed ID: 26897459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice.
    Colbert MC; Hall DG; Kimball TR; Witt SA; Lorenz JN; Kirby ML; Hewett TE; Klevitsky R; Robbins J
    J Clin Invest; 1997 Oct; 100(8):1958-68. PubMed ID: 9329959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects in cardiac conduction system lineages and malignant arrhythmias: developmental pathways and disease.
    St Amand TR; Lu JT; Chien KR
    Novartis Found Symp; 2003; 250():260-70; discussion 271-5, 276-9. PubMed ID: 12956335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac transcription factor Csx/Nkx2-5: Its role in cardiac development and diseases.
    Akazawa H; Komuro I
    Pharmacol Ther; 2005 Aug; 107(2):252-68. PubMed ID: 15925411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac function in genetically engineered mice with altered adrenergic receptor signaling.
    Rockman HA; Koch WJ; Lefkowitz RJ
    Am J Physiol; 1997 Apr; 272(4 Pt 2):H1553-9. PubMed ID: 9139936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From mouse to man: understanding heart failure through genetically altered mouse models.
    Chu G; Haghighi K; Kranias EG
    J Card Fail; 2002 Dec; 8(6 Suppl):S432-49. PubMed ID: 12555156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac hypertrophy and failure: lessons learned from genetically engineered mice.
    Takeishi Y; Walsh RA
    Acta Physiol Scand; 2001 Sep; 173(1):103-11. PubMed ID: 11678732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Embryological and genetic mechanisms of cardiac great arteries malformations].
    Bonnet D; Zaffran S; Kelly R; Bajolle F
    J Soc Biol; 2009; 203(2):161-5. PubMed ID: 19527629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone methylations in heart development, congenital and adult heart diseases.
    Zhang QJ; Liu ZP
    Epigenomics; 2015; 7(2):321-30. PubMed ID: 25942538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic animal models: new avenues in cardiovascular physiology.
    Franz WM; Mueller OJ; Hartong R; Frey N; Katus HA
    J Mol Med (Berl); 1997 Feb; 75(2):115-29. PubMed ID: 9083929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RXRalpha overexpression in cardiomyocytes causes dilated cardiomyopathy but fails to rescue myocardial hypoplasia in RXRalpha-null fetuses.
    Subbarayan V; Mark M; Messadeq N; Rustin P; Chambon P; Kastner P
    J Clin Invest; 2000 Feb; 105(3):387-94. PubMed ID: 10675365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.